Alto Neuroscience
IPO ANRO.NYSE Past

Alto Neuroscience

Biotechnology

Company website
Ticker

ANRO.NYSE

Market

us

IPO date

2/1/2024

About

Engaged in the development of treatment methods for diseases related to the nervous system and the brain. The company operates in a highly demanded segment. The global market for antidepressant drugs and treatment methods is expected to grow to $16.8 billion by 2032 from the current $10.1 billion.
_____________________________
Headquarters:

369 South San Antonio Road, Los Altos, CA 94022, USA

Meros Equity

2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.